This section focuses on the research completed to develop the SEM assessment technology foundational science and mode of operation. Including how SEM assessment technology identifies increased risk of pressure injury and how to treat a high SEM (∆) delta as a stage/category 1 pressure injury to prevent them from further deterioration.
Gershon, S., Okonkwo, H. 2021. Journal of Wound Care
Aim: To evaluate the ability of an objective test, the SEM, to discriminate between subjects with confirmed pressure injury with intact skin versus those with no pressure damage.
Budri, A. 2020. British Journal of Healthcare Management
Aim: This article reviews the use of a sub-epidermal moisture (SEM) scanning device as an early and robust method of identifying the increased risk of pressure damage before it is visible on the surface of the skin. This could allow the implementation of early interventions and potentially decrease the frequency of hospital-acquired pressure injury.
Gershon, S. 2020. Advances in Skin and Wound Care
Aim: The primary aim of this study was to determine whether levels of SEM from repeated measures at a localized area confirm the absence of a pressure injury at that site in healthy participants.
Okonkwo, H. et al. 2020. Wound Repair and Regeneration
Aim: This study aimed to evaluate the sensitivity and specificity of subepidermal moisture (SEM), a biomarker employed for early detection of pressure injury, compared to the “Gold Standard” of clinical skin and tissue assessment (STA), and to characterize the timing of SEM changes relative to the diagnosis of a pressure injury.
Peko, L. et al. 2020. International Wound Journal
Aim: We were interested in experimentally evaluating the sensitivity and laboratory performances of a second generation design of a new sub-epidermal moisture (SEM) measurement device that is able to identify localised fluid content changes in skin and subdermally, which may precede a pressure injury.
Click here to access our extensive SEM assessment technology bibliography
If you would like to discuss any of the clinical, health economic or real-world evidence on the website or would like further information on them the team would be happy to assist. Please contact us at: info@bruinbiometrics.com
"*" indicates required fields
Δ
